South Korea is now planning to invest $26.2 million in a research program using games and virtual reality to treat mental disorders.
The South Korean Ministry of Science and Information and Communications technology is now planning to invest 30 billion. It will be used for the research program to develop a digital treatment for depression.
The number of people in South Korea with depression in 2019 has gone up to 800000. The figure projected here is also continuing to rise due to the impacts of the restrictions regarding the COVID-19.
This research program will see the development of the digital service offering. The service will also get the personalization for the depression diagnosis based on the patient data. The system will collect the data in real-time and perform an analysis of it.
The service will also offer many preventive measures against mental illness. It will utilize smartphones and other mobile devices. The potential digital treatment will come with games and virtual reality.
The report has noted that the Naver Cloud of the South Korean internet giant Naver Corp has been assigned to build a cloud infrastructure. This infrastructure will also have a design suitable for the digital platform of the program.
The digitally-enabled treatments are the alternative to the conventional method of treatment for mental health. Last month South Korean telecommunication from the KT Corporation entered into a partnership with NeuroSigma. They will jointly develop and market the new electronic therapies for neurophysical and neurological disorders. It will help to treat ADHD, depression, and epilepsy.
A year ago, Orexo unveiled its latest digital treatment, deprexis, to treat the symptoms of depression. Another digital health company UpLift Health has created a mobile application that uses cognitive behavioral therapy. It helps people to deal with depression. It also offers 12 rounds of 45 minutes of guided sessions through chatbots. Users here can answer the questions to take mental health exercises. They can also receive feedback and guidance.
The subsidiary of Google’s parent Alphabet, X has disclosed in November that it has been working on a project called Amber. It is also capable of spotting the biomarkers of depression.